This retrospective review examined 10 chronic diabetic foot ulcer patients treated with novel purified reconstituted bilayer matrix to assess safety and efficiency with a primary endpoint of wound closure at 12 weeks.
This retrospective review examined 10 chronic diabetic foot ulcer patients treated with novel purified reconstituted bilayer matrix to assess safety and efficiency with a primary endpoint of wound closure at 12 weeks.
This retrospective review...